Vietnam Investment Review on MSN
Kazia Therapeutics appoints Sudha Rao as chief scientific officer
SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results